Search
for
Sort by
Research 391–420 of 787
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Real-world evidence in alopecia areata treatment: A narrative review
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- New and Emerging Therapies for Alopecia Areata
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Disease-related biomarkers as experimental endpoints in 3D skin culture models
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- <div>Six years of the IP Indian Journal of Clinical and Experimental Dermatology (2019-2025):&nbsp;<span style="font-size: 1rem;">A bibliometric and thematic analysis</span></div>
- Effects of Natural Herbal Marker Compounds on Human Dermal Papilla Cell Growth Regulation
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- Microarray Gene Expression Analysis of Lesional Skin in Canine Pemphigus Foliaceus
- Hair Disorders in Autoimmune Diseases
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Hair Loss in an 11-year-old
- Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier
- Alopecia Areata: Clinical Treatment
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- The orchestrated network of skin photoaging: From intercellular crosstalk to molecular signaling
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia